David Moore to CD4 Lymphocyte Count
This is a "connection" page, showing publications David Moore has written about CD4 Lymphocyte Count.
Connection Strength
0,721
-
Inflammation Relates to Poorer Complex Motor Performance Among Adults Living With HIV on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2019 01 01; 80(1):15-23.
Score: 0,136
-
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011 Nov 09; 343:d6884.
Score: 0,083
-
Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS. 2007 Mar 30; 21(6):713-9.
Score: 0,060
-
Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol. 2003 Oct; 60(10):1406-12.
Score: 0,047
-
Low CD4+ cell count nadir exacerbates the impacts of APOE e4 on functional connectivity and memory in adults with HIV. AIDS. 2021 04 01; 35(5):727-736.
Score: 0,040
-
Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS. 2020 11 01; 34(13):1907-1914.
Score: 0,038
-
Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 12 01; 33(15):2309-2316.
Score: 0,036
-
Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis. Sci Rep. 2016 09 06; 6:32947.
Score: 0,029
-
The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 Jul 31; 29(12):1483-91.
Score: 0,027
-
Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort. Int J Epidemiol. 2015 Feb; 44(1):58-67.
Score: 0,024
-
Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. J Neurovirol. 2013 Oct; 19(5):410-7.
Score: 0,023
-
Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013 Jan 22; 80(4):371-9.
Score: 0,022
-
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/µL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012 Apr; 54(8):1204-11.
Score: 0,021
-
Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr. 2011 Aug 15; 57(5):371-9.
Score: 0,020
-
Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses. 2012 Jan; 28(1):95-9.
Score: 0,020
-
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr. 2010 Dec; 55(4):451-9.
Score: 0,019
-
Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):28-35.
Score: 0,018
-
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr. 2008 Mar 01; 47(3):304-11.
Score: 0,016
-
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007 Mar 30; 21(6):685-92.
Score: 0,015
-
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. AIDS. 2006 May 12; 20(8):1117-23.
Score: 0,014
-
The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004 May; 10(3):317-31.
Score: 0,012